We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

18 hedge funds and large institutions have $1.32M invested in Acer Therapeutics Inc in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

35% less capital invested

Capital invested by funds: $2.01M → $1.32M (-$696K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$76.3K
2
Goldman Sachs
Goldman Sachs
New York
+$33.5K
3
U
UBS
Switzerland
+$30.5K
4
Citadel Advisors
Citadel Advisors
Florida
+$25.4K
5
Creative Planning
Creative Planning
Kansas
+$24.9K

Top Sellers

Rank Fund Capital Flow
1
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$23.5K
2
GC
Guggenheim Capital
Illinois
-$17K
3
Wells Fargo
Wells Fargo
California
-$13K
4
TRCT
Tower Research Capital (TRC)
New York
-$5.46K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$627K +$11K +93 +1%
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$264K – – –
SKK
3
Shepherd Kaplan Krochuk
Massachusetts
$99K -$23.5K -198 -14%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$73K – – –
VKH
5
Virtu KCG Holdings
New York
$53K +$76.3K +643 New
Northern Trust
6
Northern Trust
Illinois
$45K – – –
Goldman Sachs
7
Goldman Sachs
New York
$33K +$33.5K +282 +231%
MC
8
Moors & Cabot
Massachusetts
$31K – – –
U
9
UBS
Switzerland
$23K +$30.5K +257 +988%
Citadel Advisors
10
Citadel Advisors
Florida
$18K +$25.4K +214 New
Creative Planning
11
Creative Planning
Kansas
$17K +$24.9K +210 New
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$11K +$15.7K +132 New
PGFC
13
Peapack-Gladstone Financial Corp
New Jersey
$9.93K – – –
BIM
14
BlackRock Investment Management
Delaware
$5K – – –
Morgan Stanley
15
Morgan Stanley
New York
$4K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$2K -$5.46K -46 -62%
Citigroup
17
Citigroup
New York
$1K +$1.31K +11 New
GC
18
Guggenheim Capital
Illinois
– -$17K -122 Closed
Wells Fargo
19
Wells Fargo
California
– -$13K -97 Closed

ACER Hedge Fund Activity: Q3 2014 in Review

18 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2014, worth a combined $1.32M — down 35% from $2.01M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ACER positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $76.3K. The largest seller was Shepherd Kaplan Krochuk, cutting an estimated $23.5K.

  • 18 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2014, up from 16 in Q2 2014.
  • Funds reported $1.32M of Acer Therapeutics Inc stock for Q3 2014, down 35% quarter-over-quarter.
  • 5 funds opened new Acer Therapeutics Inc positions in Q3 2014 and 3 closed out, a net change of +2 holders.
  • The largest Acer Therapeutics Inc buyer in Q3 2014 was Virtu KCG Holdings, an estimated $76.3K added.
  • The largest Acer Therapeutics Inc seller in Q3 2014 was Shepherd Kaplan Krochuk, an estimated $23.5K sold.

Based on aggregated 13F filings for Q3 2014.